[1] Duehrkop C, Bznz Y, Spirig R, et al. C1 Esterase Inhibitor Reduces Lower Extremity Ischemia/Reperfusion Injury and Associated Lung Damage[J]. PLoS One, 2013, 8(8):1-15. [2] 门秀丽, 熊建新, 李宏杰, 等. 牛磺酸对大鼠肢体缺血/再灌注后肺损伤时磷脂酶A2的影响[J]. 中国应用生理学杂志, 2007, 23(4):466-512. [3] Korthuis RJ, Granger DN, Townsley MI, et al. The role of oxygen-derived free radicals in ischemia induced increases in canine skeletal muscle vascular permeability[J]. Circ Res, 1985, 57(4):599-609. [4] Mimuro S, Katoh T, Suzuki A, et al. Deterioration of myocardial injury due to dexmedetomidine administration after myocardial ischaemia[J]. Resuscitation, 2010, 81(12):1714-1717. [5] Si Y, Bao H, Han L, et al. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation[J]. J Transl Med, 2013, 9(11):141. [6] Jiang L, Li L, Shen J, et al. Effect of dexmedetomidine on lung ischemia reperfusion injury[J]. Mol Med Reports, 2014, 9(2):419-426. [7] Ibacache M, Sanchez G, Pedrozo Z, et al. Dexmedetomidine preconditionong activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart[J]. Biochim Biophys Acta, 2012, 1822(4):537-545. [8] Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice[J]. Crit Care, 2011, 15(3):R153. [9] Jian Z, Li K, Liu L, et al. Heme oxygenase-1 protects human melanocytes from H2O2-induced oxidative stress via the Nrf2-ARE pathway[J]. J Invest Dermatol, 2011, 131(7):1420-1427. [10] Xu D, Xing Q, Li Y, et al. Dexmedetomidine protects against ischemia-reperfusion injury in rat skeletal muscle[J]. J Surg Res, 2014, 186(1):240-245. [11] Zhang XY, Liu ZM, Wen SH, et al. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats[J]. Anesthesiol, 2012, 116(5):1035-1046. [12] Avci G, Kadioglu H, Sehirli AO, et al. Curcumin protects against ischemia/reperfusion injury in rat skeletal muscle[J]. J Surg Res, 2012, 172(1):e39-46. [13] Kwark MK, Wakabayashi N, Kensler TW. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers[J]. Mutal Res, 2004, 555(1-2):133-148. [14] McMahon M, Itoh K, Yamamoto M, et al. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression[J]. J Biol Chem, 2003, 278(24):21592-21600. [15] 江刚, 戴爱国. PI3k/Akt-aPKC-Nrf2调控大鼠气道上皮细胞γ-谷氨酰半胱氨酸合成酶表达[J]. 中国应用生理学杂志, 2011, 27(1):115-119. |